Brief: First Wave Biopharma Announces Exclusive Global License Agreement For Capeserod From Sanofi

GridAI Technologies

14/09/2023 12:14

First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ANNOUNCES EXCLUSIVE GLOBAL LICENSE
AGREEMENT FOR CAPESEROD FROM SANOFI
    * FIRST WAVE BIOPHARMA INC: ANNOUNCED AN AGREEMENT WITH
SANOFI
    * FIRST WAVE BIOPHARMA- FIRST WAVE TO GET FROM SANOFI AN
EXCLUSIVE, GLOBAL LICENSE FOR CAPESEROD, ASSUME RESPONSIBILITY
FOR FUTURE CLINICAL DEVELOPMENT
    * FIRST WAVE BIOPHARMA INC- TO INITIATE TALKS WITH FDA ON
DEVELOPMENT, REGULATORY PLAN, TO BEGIN PHASE 2 CLINICAL TRIALS
OF CAPESEROD IN 2024

Source text for Eikon:  ID:nGNX9B5QDY 
Further company coverage:  FWBI.O